A Republican bill with 2 Democratic cosponsors · See all 5 cosponsors
Last activity — Referred to the Subcommittee on Health.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the IBOGAINE Act, aims to speed up the development and access to psychedelic drugs to address serious mental illness in the United States. It establishes a National Health Priority Voucher Pilot Program to incentivize the development of high-priority medical products. The legislation amends the Federal right to try law and creates special registration requirements for physicians to administer Schedule I drugs. It also mandates revisions to DEA production quotas and encourages collaboration between federal agencies, states, and the private sector. Additionally, it directs the Department of Veterans Affairs to designate a senior official and develop workforce readiness plans for emerging therapeutic interventions. Finally, the bill requires reports on the acceleration of medical treatments for serious mental illness.
Yes· 3 of 11
- Scored +8
Does this make mental health care easier to get?
The bill specifically aims to accelerate access to psychedelic drugs to treat serious mental illness.
- Scored +8
Does this help veterans get medical care?
The bill directs the VA to develop workforce readiness and implementation plans for emerging therapeutic interventions.
- Scored +8
Would veterans be better off under this, taking everything together?
The bill provides specific mandates for the VA to implement and train for emerging therapies.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Access to Life-Saving Treatments: The bill seeks to accelerate the development of and access to psychedelic drugs that could save lives and reverse the crisis of serious mental illness (Introduction).
-
Incentivizing Breakthrough Medical Products: The National Health Priority Voucher Pilot Program awards vouchers to sponsors of products that address public health crises, unmet medical needs, or improve healthcare affordability (Section 4).
-
Enhanced Physician Authority under Right to Try: The bill amends the Federal right to try law to include provisions regarding the unauthorized use, possession, and distribution of eligible investigational drugs (Section 5).
-
Streamlined Medical Research and Quotas: The bill requires the Attorney General to revise production quotas for controlled substances within specific timeframes if a drug is approved or designated as a breakthrough therapy (Section 7).
-
Support for Research via Partnerships: The Secretary of Health and Human Services may partner with States, territories, and Indian Tribes to advance research on psychedelic drugs (Section 8).
-
Improved Veteran Care and Training: The Department of Veterans Affairs is tasked with developing a workforce implementation-readiness plan to ensure clinicians are trained for safe and effective implementation of emerging therapies (Section 12).
Potential Negative Impacts for People
-
Potential Costs to Sponsors: The Secretary may establish a user fee program that requires sponsors of a national health priority product application to pay a fee (Section 4, subsection c).
-
Strict Requirements for Physicians: Physicians wishing to administer Schedule I drugs must undergo a specific registration process, which includes providing evidence of compliance, documentation from manufacturers, and descriptions of storage sites (Section 6).
-
Regulatory Oversight of Possession: Physicians treating patients with Schedule I drugs are limited to possessing only the specific amounts of the drug identified in their application or supplemental notification (Section 6).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make mental health care easier to get? — The bill specifically aims to accelerate access to psychedelic drugs to treat serious mental illness. Does this help veterans get medical care? — The bill directs the VA to develop workforce readiness and implementation plans for emerging therapeutic interventions. Does this do more about addiction and overdose deaths? — The bill targets neuroplasticity and compounds that interrupt addiction cycles. Does this make health care easier to get in general? — The voucher program is intended to enhance access to important health care products. Does this put more money into medical research? — The bill encourages research through federal-state partnerships and interagency collaboration.
- Demographic And Interest Groups
- Would veterans be better off under this, taking everything together? — The bill provides specific mandates for the VA to implement and train for emerging therapies. Would business owners be better off under this? — The voucher program incentivizes drug development for sponsors.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill mandates various reports to Congress regarding therapeutic interventions. Does this give the federal government more power? — The bill expands federal authority in rescheduling and drug production quota management.
- National Security And Foreign Policy
- Does this increase the pay, pensions or support veterans receive? — The bill enhances healthcare options and workforce readiness for veterans dealing with mental illness.
- Education And Technology
- Does this put more money into scientific research? — The bill promotes drug development through priority review vouchers and interagency collaboration.
- 9/15/2026
- 1 Cosponsor added.
- 8/31/2026
- 1 Cosponsor added.
- 7/17/2026
- Referred to the Subcommittee on Health.
- 6/30/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 3 Cosponsors added.
- Introduced in House
2 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Jack BergmanRepublican · Michigan
J. CorreaDemocrat · California
Mike CollinsRepublican · Georgia
Sarah ElfrethDemocrat · Maryland
Michael McCaulRepublican · Texas